ArticleAnnals of internal medicine2021

Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD.

Qiukui Hao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.